Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS | NEJM - nejm.org

Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS | NEJM  nejm.org'Truly remarkable' drug can reverse decline caused by motor neurone disease - BBC News  BBC NewsBiogen says ALS drug shows clinical benefit in new data analysis  ReutersNew genetically-targeted MND therapy could be a turning point for patient care  News-Medical.Net'Truly remarkable' drug helps motor neurone disease  BBCView Full Coverage on Google News